Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. J. McCargar
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
Breast Care
Surgery
Oncology
Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Financial Toxicity in Metastatic Cancer Patients Receiving Stereotactic Radiosurgery
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Metastatic Breast Cancer: Focus on Capecitabine
Clinical Medicine Reviews in Oncology
Individually Tailored Treatment With Epirubicin and Paclitaxel With or Without Capecitabine as First-Line Chemotherapy in Metastatic Breast Cancer: A Randomized Multicenter Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Cancers
Cancer Research
Oncology
Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
